Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA nanodelivery systems: targeting strategies and administration routes
Mujie Yuan, Zeyu Han, Yan Liang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115302-115302
Open Access | Times Cited: 6
tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer
Bo Zhang, Yi Pan, Zhe Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery
Nipuni Maniyamgama, Ki Hyun Bae, Zi Wei Chang, et al.
Advanced Science (2025)
Open Access
Advancements in Nanomedicine for the Diagnosis and Treatment of Kidney Stones
Wang Yong-qi, Junyi Yang, Yirixiatijiang Amier, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1401-1423
Open Access
Targeting Strategies for Site-Specific mRNA Delivery
Jiaxing Di, Pei Huang, Xiaoyuan Chen
Bioconjugate Chemistry (2024) Vol. 35, Iss. 4, pp. 453-456
Closed Access | Times Cited: 4
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 4
Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 3
Nano-Encapsulation and Conjugation Applied in the Development of Lipid Nanoparticles Delivering Nucleic Acid Materials to Enable Gene Therapies
Linh Đinh, Lanesa Mahon, Bingfang Yan
Applied Nano (2024) Vol. 5, Iss. 3, pp. 143-161
Open Access | Times Cited: 3
Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations and Applications
Teenu Sharma, M. Arockia Babu, Atul Jain, et al.
Nanoscience & Nanotechnology-Asia (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 2
Recent Advances and Prospects in RNA Drug Development
Hidenori Tani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12284-12284
Open Access | Times Cited: 2
Progress on mRNA vaccines and lipid nanoparticles
Yuchuan Fan, Han Yin, Yu Li, et al.
Chinese Science Bulletin (Chinese Version) (2024)
Open Access
COVID-19 vaccine development and distribution
Jean‐Louis Excler, Lois Privor-Dumm, Jérôme H. Kim
Elsevier eBooks (2024), pp. 153-164
Closed Access
Vaccine approaches to treat urothelial cancer
Giulia Claire Giudice, Guru P. Sonpavde
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
GREM1 may be a biological indicator and potential target of bladder cancer
Qingxin Yu, Shanshan Xu, Shouxiang Weng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A breath of fresh air: targeted non-viral in vivo gene correction in the mammalian lung
Jixin Liu, Dirk Grimm
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access
Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition
Yu‐Li Lo, Ci-Jheng Hong, Chen-Shen Wang, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 10-11, pp. 829-853
Open Access
Development of Self‐Adjuvants in mRNA Vaccine and Its Application in Disease Prevention and Treatment
Huaibin Yu, Yafang Lu, Zhi‐Feng Miao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Better, Faster, Stronger: Accelerating mRNA‐Based Immunotherapies With Nanocarriers
Henrique Carvalho, Tiago A. S. Fidalgo, Rita C. Acúrcio, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma
Tianmei Fu, Boxuan Zhou, Yingliang Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13183-13199
Open Access
Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity
Mahboubeh Hosseini-Kharat, Kristen E. Bremmell, Branka Grubor‐Bauk, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 170-194
Open Access
Research progress of mosquito-borne virus mRNA vaccines
Ning Sun, Zhiwei Su, Zheng Xiao-yan
Molecular Therapy — Methods & Clinical Development (2024) Vol. 33, Iss. 1, pp. 101398-101398
Open Access
Page 1

Scroll to top